Ole Jannik Bjerrum

Ole Jannik Bjerrum

Professor, emeritus


  1. 2019
  2. Published

    Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy

    Bjerrum, Ole Jannik, Eichendorff, S. & Alkis, N. B., 2019, In: Therapeutic Innovation & Regulatory Science. 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Body of evidence and approaches applied in the clinical development programme of fixed-dose combinations in the European Union from 2010 to 2016

    Nøhr-Nielsen, A., De Bruin, M. L., Thomsen, M., Pipper, C. B., Lange, Theis, Bjerrum, Ole Jannik & Lund, Trine Meldgaard, 2019, In: British Journal of Clinical Pharmacology. 85, 8, p. 1829-1840 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published
  5. Published

    Glutamate transport system as a key constituent of glutamosome: Molecular pathology and pharmacological modulation in chronic pain

    Gegelashvili, G. & Bjerrum, Ole Jannik, 2019, In: Neuropharmacology. 161, 107623.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Mechanical sensory threshold in Cavalier King Charles spaniels with syringomyelia-associated scratching and control dogs

    Thoefner, M. S., Westrup, U., Toft, N., Bjerrum, Ole Jannik & Berendt, Mette, 2019, In: Veterinary Journal. 246, p. 92-97 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 1302721